Abstract
Lysine-rich peptide, designated as KABT-AMP, was designed and synthesized to supersede the irrational use of chemical antibiotics as standard therapy. KABT-AMP is a 22-amino acid helical cationic peptide (+10) and amphipathic in nature. The antimicrobial kinetics of the peptide was ascertained in the representative strains of gram-positive, gram-negative, and fungal strains, viz., Staphylococcus aureus MTCC 2940, Escherichia coli MTCC 2939, and Candida albicans MTCC 227, respectively. KABT-AMP was synthesized by solid-phase synthesis and purified using reverse-phase high-performance liquid chromatography which resulted in >95 % purity, and matrix-assisted laser desorption/ionization time of flight revealed the mass of the peptide to be 2.8 kDa. KABT-AMP showed significant broad-spectrum antimicrobial activity against the bacterial and fungal strains analyzed in the present study with survivability of 30.8, 30.6, and 31.7 % in E. coli, S. aureus, and C. albicans, respectively, at 6 h. KABT-AMP also demonstrated antibiofilm activity against the tested biofilm forming clinical isolate, Candida tropicalis. The putative membranolytic activity of the peptide was substantiated by electron microscopic analysis. Results reveal that KABT-AMP will exhibit noteworthy antimicrobial activity against multidrug-resistant bacteria and fungus at micromolar concentrations with minimal cytotoxicity and thus could be conceived for biomedical application.
Similar content being viewed by others
References
Gupta, K., Scholes, D., & Stamm, W. E. (1999). Journal of the American Medical Association, 281, 736–738.
Foxman, B., Barlow, R., D’Arcy, H., Gillespie, B., & Sobel, J. D. (2000). Annals of Epidemiology, 10, 509–515.
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006). Journal of Antimicrobial Chemotherapy, 57, 589–608.
Maenza, J. R., Merz, W. G., Romagnoli, M. J., Keruly, J. C., Moore, R. D., & Gallant, J. E. (1997). Clinical Infectious Disease, 24, 28–34.
Wang, Z., & Wang, G. (2004). Nucleic Acids Research, 32, D590–D592.
Wang, G., Li, X., & Wang, Z. (2009). Nucleic Acids Research, 37, D933–D937.
Iwakoshi-Ukena, E., Okadab, G., Okimotob, A., Fujii, T., Sumidac, M., & Ukena, K. (2011). Peptides, 32, 2052–2057.
Zaiou, M. (2007). Journal of Molecular Medicine (Berl), 85, 317–329.
Bommariusa, B., Jenssen, H., Elliott, M., Kindrachuk, J., Pasupuleti, M., Gieren, H., et al. (2010). Peptides, 31, 1957–1965.
Oyston, P. C. F., Fox, M. A., Richards, S. J., & Clark, G. C. (2009). Journal of Medical Microbiology, 58, 977–987.
Seo, M. D., Won, H. S., Kim, J. H., Mishig-Ochir, T., & Lee, B. J. (2012). Molecules (Basel, Switzerland), 17, 12276–12286.
Giacometti, A., Cirioni, O., Barchiesi, F., Del Prete, M. S., & Scalise, G. (1999). Peptides, 20, 1265–1273.
Tossi, A., Sandri, L., & Giangaspero, A. (2000). Peptide Science, 55, 4–30.
Chou, H.-T., Wen, H.-W., Kuo, T.-Y., Lin, C.-C., & Chen, W.-J. (2010). Peptides, 31, 1811–1820.
Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E., Vasil, M. L., & Hodges, R. S. (2005). The Journal of Biological Chemistry, 280, 12316–12329.
Deslouches, B., Phadke, S. M., Lazarevic, V., Cascio, M., Islam, K., Montelaro, R. C., et al. (2005). Antimicrobial Agents and Chemotherapy, 49, 316–322.
Jin, Y., Hammer, J., Pate, M., Zhang, Y., Zhu, F., Zmuda, E., et al. (2005). Antimicrobial Agents and Chemotherapy, 49, 4957–4964.
Chou, H. T., Kuo, T. Y., Chiang, J. C., Pei, M. J., Yang, W. T., Yu, H. C., et al. (2008). International Journal of Antimicrobial Agents, 32, 130–138.
Duval, E., Zatylny, C., Laurencin, M., Baudy-Floc’h, M., & Henry, J. (2009). Peptides, 30, 1608–1612.
Chou, P. Y., & Fasman, G. D. (1974). Biochemistry, 13, 211–222.
Blondelle, S. E., & Houghten, R. A. (1992). Biochemistry, 31, 12688–12694.
Thormann, K. M., Saville, R. M., Shukla, S., Pelletier, D. A., & Spormann, A. M. (2004). Journal of Bacteriology, 186, 8096–8104.
Crick, F. H. (1952). Nature, 170, 882–883.
Pauling, L., & Corey, R. B. (1953). Nature, 171, 59–61.
Gopal, R., Seo, C. H., Song, P. I., & Park, Y. (2012). Amino Acids. doi:10.1007/s00726-012-1388-6.
Lee, S. H., Kim, S. J., Lee, Y. S., Song, M. D., Kim, I. H., & Won, H. S. (2011). Regulatory Peptides, 166, 36–41.
Meincken, M., Holroyd, D. L., & Rautenbach, M. (2005). Antimicrobial Agents and Chemotherapy, 49, 4085–4092.
Fux, C. A., Stoodley, P., Hall-Stoodley, L., & Costerton, J. W. (2003). Expert Review of Anti-Infective Therapy, 1, 667–683.
Shanmughapriya, S., Lency Francis, A., Kavitha, S., & Natarajaseenivasan, K. (2012). Biofouling: The Journal of Bioadhesion and Biofilm Research, 28, 929–935.
Acknowledgments
This work was supported by DST-INSPIRE and ICMR JRF fellowship to first and second authors and UGC, DST-YS, and DST-Indo-Japan cooperative grant projects.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thankappan, B., Jeyarajan, S., Hiroaki, S. et al. Antimicrobial and Antibiofilm Activity of Designed and Synthesized Antimicrobial Peptide, KABT-AMP. Appl Biochem Biotechnol 170, 1184–1193 (2013). https://doi.org/10.1007/s12010-013-0258-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0258-3